Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk.

Published on Sep 1, 2014in Biomedical Reports
· DOI :10.3892/BR.2014.305
Yasuaki Enokida5
Estimated H-index: 5
(Gunma University),
Kimihiro Shimizu33
Estimated H-index: 33
(Gunma University)
+ 19 AuthorsIzumi Takeyoshi30
Estimated H-index: 30
(Gunma University)
Sources
Abstract
Murine double minute 2 (MDM2) is a negative regulator of p53. A single-nucleotide polymorphism (SNP) (rs2279744: c.309T>G) in the promoter region of the MDM2 gene has been shown to result in higher levels of MDM2 RNA and protein. Regarding the contribution of c.309T>G in the MDM2 gene to the lung cancer risk, previous studies are conflicting. In order to evaluate the association between c.309T>G and the lung cancer risk, a case-control study was performed. The MDM2 genotypes were determined in 762 lung cancer patients and in 700 cancer-free control subjects using the Smart Amplification Process. Statistical adjustment was performed for gender, age and pack-years of smoking. The distributions of c.309T>G (T/T, T/G, G/G) were 20.1, 49.7, 30.2% in the case group and 21.7, 47.9, 30.4% in the healthy-control group. There were no overall associations between the MDM2 genotypes and the risk of lung cancer [T/G genotype: Adjusted odds ratio (AOR), 1.30; 95% confidence interval (CI), 0.88–1.93; and G/G genotype: AOR, 1.18; 95% CI, 0.78–1.80]. The subgroup analysis of gender, histology, smoking status and epidermal growth factor receptor mutation status also indicated that there was no association with lung cancer. Additionally, the genotypes did not have an effect on the age at the time of diagnosis of lung cancer (P=0.25). In conclusion, the G allele frequency in the lung cancer cases was 0.551, which was similar to other studies. The results of the present study suggest that the c.309T>G is not significantly associated with lung cancer.
📖 Papers frequently viewed together
32 Citations
29 Citations
References45
Newest
#1Serge P. Nana-Sinkam (OSU: Ohio State University)H-Index: 15
#2Charles A. Powell (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 49
Based on recent bench and clinical research, the treatment of lung cancer has been refined, with treatments allocated according to histology and specific molecular features. For example, targeting mutations such as epidermal growth factor receptor (EGFR) with tyrosine kinase inhibitors has been particularly successful as a treatment modality, demonstrating response rates in selected patients with adenocarcinoma tumors harboring EGFR mutations that are significantly higher than those for conventi...
57 CitationsSource
#1Yasuaki Enokida (Gunma University)H-Index: 5
#2Kimihiro Shimizu (Gunma University)H-Index: 33
Last. Izumi Takeyoshi (Gunma University)H-Index: 30
view all 19 authors...
Background Genetic polymorphisms in the human MDM2 gene are suggested to be a tumor susceptibility marker and a prognostic factor for cancer. It has been reported that a single nucleotide polymorphism (SNP) c.309T>G in the MDM2 gene attenuates the tumor suppressor activity of p53 and accelerates tumor formation in humans. Methodology In this study, to detect the SNP c.309T>G in the MDM2 gene, we have developed a new SNP detection method, named “Duplex SmartAmp,” which enabled us to simultaneousl...
8 CitationsSource
#1Yangwu Ren (PRC: China Medical University (PRC))H-Index: 15
#2Zhihua Yin (PRC: China Medical University (PRC))H-Index: 22
Last. Baosen ZhouH-Index: 30
view all 7 authors...
Background: Cell cycle deregulation is a major component of carcinogenesis. The p53 tumor suppressor gene plays an important role in regulating cell cycle arrest, and mouse double minute 2 (MDM2) is a key regulator of p53 activity and degradation. Abnormal expression of p53 and MDM2 occurs in various cancers including lung cancer. Methods: We investigated the distribution of the p53 Arg72Pro (rs1042522) and MDM2 SNP309 (rs2279744) genotypes in patients and healthy control subjects to assess whet...
21 CitationsSource
#1Bríd M. Ryan (NIH: National Institutes of Health)H-Index: 21
#2Kara Calhoun (NIH: National Institutes of Health)H-Index: 2
Last. Curtis C. Harris (NIH: National Institutes of Health)H-Index: 150
view all 7 authors...
Conflicting reports exist regarding the contribution of SNP309 in MDM2 to cancer risk. Recently, SNP285 was shown to act as an antagonist to SNP309 by overriding the effect of SNP309 on SP1-mediated transcription. Moreover, SNP285 modified the relationship between SNP309 and risk of breast, ovarian and endometrial cancer. We assessed whether SNP285 confounded the effect of SNP309 in lung cancer in a cohort of 720 controls and 556 cases. Our cohort included both Caucasians and African Americans. ...
19 CitationsSource
Qing Lan and colleagues report the results of a genome-wide association study of lung cancer in never-smoking women from Asia. They identify three new susceptibility loci and confirm three other previously reported associations.
230 CitationsSource
#1Wenwu He (Guangxi Medical University)H-Index: 4
#2Jianxiong Long (Guangxi Medical University)H-Index: 15
Last. Yanling Hu (Guangxi Medical University)H-Index: 5
view all 8 authors...
Lung cancer is the most common diagnosed malignancy and the leading cause of cancer-related mortality worldwide. Murine double minute 2 (MDM2) SNP309 polymorphisms have been reported to influence the risk of lung cancer. However, the published studies together with four subsequent meta-analyses have yielded contradictory results. To examine this inconsistency, we conducted a meta-analysis of 6,696 lung cancer cases and 7,972 controls from eight published case-control studies using METAGEN. Odds ...
6 CitationsSource
#1Kouya ShiraishiH-Index: 26
#2Hideo Kunitoh (Memorial Hospital of South Bend)H-Index: 54
Last. Takashi KohnoH-Index: 86
view all 18 authors...
Takashi Kohno and colleagues identify two new susceptibility loci for lung adenocarcinoma in the Japanese population. They also replicate previously identified risk loci near TERT and TP63.
136 CitationsSource
#1Wenlei Zhuo (Third Military Medical University)H-Index: 15
#2Liang Zhang (Third Military Medical University)H-Index: 9
Last. Zhengtang Chen (Third Military Medical University)H-Index: 25
view all 5 authors...
Background Evidence suggests that MDM2 T309G polymorphism may be a risk factor for several cancers. Increasing investigations have been conducted on the association of MDM2 T309G polymorphisms with lung cancer risk and have yielded conflicting results. Previous meta-analyses on this issue have reported inconclusive data. The aim of the present study was to derive a more precise estimation of the relationship. Methods and Findings Updated meta-analyses examining the association between MDM2 T309G...
23 CitationsSource
#1Myung-Ju Ahn (SKKU: Sungkyunkwan University)H-Index: 80
#2Hong-Hee Won (SMC: Samsung Medical Center)H-Index: 30
Last. Keunchil Park (SKKU: Sungkyunkwan University)H-Index: 47
view all 16 authors...
The proportion of never smoker non-small cell lung cancer (NSCLC) in Asia is about 30–40%. Despite the striking demographics and high prevalence of never smoker NSCLC, the exact causes still remain undetermined. Although several genome wide association (GWA) studies were conducted to find susceptibility loci for lung cancer in never smokers, no regions were replicated except for 5p15.33, suggesting locus heterogeneity and different environmental toxic effects. To identify genetic loci associated...
42 CitationsSource
#1H. Dean Hosgood (NIH: National Institutes of Health)H-Index: 53
#2Wen Chang Wang (NHRI: National Health Research Institutes)H-Index: 13
Last. Qing Lan (NIH: National Institutes of Health)H-Index: 94
view all 84 authors...
A recent genome-wide association study (GWAS) of subjects from Japan and South Korea reported a novel association between the TP63 locus on chromosome 3q28 and risk of lung adenocarcinoma (p = 7.3 × 10−12); however, this association did not achieve genome-wide significance (p ≤ 10−7) among never-smoking males or females. To determine if this association with lung cancer risk is independent of tobacco use, we genotyped the TP63 SNPs reported by the previous GWAS (rs10937405 and rs4488809) in 3,46...
31 CitationsSource
Cited By4
Newest
#1Mahsa Sadat Hashemi Doulabi (IAU: Islamic Azad University)H-Index: 2
#2Reza Goleyjani Moghaddam (IAU: Islamic Azad University)H-Index: 1
Last. Ali Salehzadeh (IAU: Islamic Azad University)H-Index: 12
view all 3 authors...
Ulcerative colitis is a form of inflammatory bowel disease characterized by chronic inflammation of the colon and rectum. The abnormal lesions in the digestive system caused by ulcerative colitis and intermittent colitis are of major clinical importance. MDM2 is a phospho-protein that functions as a ubiquitin ligase for p53. Recently, a T>G substitution in the promoter of the MDM2 gene (rs309) has been identified. In this case-control study, 174 ulcerative colitis biopsy samples and 82 control s...
3 CitationsSource
#1Arunagiri Kuha Deva Magendhra Rao (University of Madras)H-Index: 8
#2Mayakannan Manikandan (University of Madras)H-Index: 11
Last. Arasambattu Kannan Munirajan (University of Madras)H-Index: 22
view all 10 authors...
Abstract Background and aim Genetic susceptibility to cancer through single nucleotide polymorphisms - p53 Pro72Arg, p73 G4C14-A4T14 (two linked polymorphism) and MDM2 T309G has been reported in various ethnic populations. Yet the association is unclear in oral cancer of Indian origin where tobacco chewing is widely practiced. The aim of the study was to evaluate the significance of these polymorphisms for the development of oral cancer. Materials and methods Single Nucleotide Polymorphisms were...
2 CitationsSource
#1Yasuaki Enokida (Gunma University)H-Index: 5
#2Kimihiro Shimizu (Gunma University)H-Index: 33
Last. Izumi Takeyoshi (Gunma University)H-Index: 30
view all 16 authors...
The MDM2 protein plays an important role in the regulation of cell proliferation and apoptosis via ubiquitination and proteasome-mediated degradation of p53. The genetic polymorphism rs2279744 (c.309T>G) of the MDM2 gene is reportedly associated with susceptibility and/or prognosis in various cancers. In this study, we investigated the risk factors for worse survival in patients with lung adenocarcinoma (AC). We examined the association between c.309T>G and the prognosis of lung cancer by retros...
2 CitationsSource
#1Li XuH-Index: 3
#2Mingyuan Yang ('SMMU': Second Military Medical University)H-Index: 9
Last. He-zhong ChenH-Index: 1
view all 7 authors...
The purpose of this articles is to determine whether the cytochrome P450 2E1 (CYP2E1) Rsa I/Pst I gene polymorphism is correlated with respiratory system cancers. Respiratory system cancers included lung cancer, laryngeal cancer, nasopharyngeal cancer, and cancers of other respiratory organs, which are the most common malignant tumors worldwide; the significant relationship between CYP2E1 Rsa I/Pst I gene polymorphism and some respiratory system cancer have been reported, but results of some oth...
5 CitationsSource